Multimodal microscope system for pharmaceutical particle analysis
Past New Requirement Updated
- Agency
-
Food and Drug Administration
Department of Health and Human Services
- Solicitation expected
- Estimated value
- $700,000 to $1,500,000
- Set-aside
- No set-aside
Forecast facts
- Anticipated award
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- Points of contact
-
- CDER Acquisition Liaison cderacquisitions@fda.hhs.gov
Forecast details come from HHS's procurement forecast. Agencies' dates and values are estimates.
About this forecast
The Food and Drug Administration (FDA) is forecasting a new requirement for a multimodal microscope system designed for pharmaceutical particle analysis. The procured system, the mIRage-LS sub-micron IR multimodal microscope, will integrate Optical Photothermal Infrared (O-PTIR) spectroscopy with simultaneous Raman and fluorescence microscopy capabilities to enable comprehensive particle characterization at spatial resolutions below 500nm. The solicitation is expected to be released on July 1, 2025, with an estimated contract award date of January 1, 2026.
The estimated award value ranges from $700,000 to $1,500,000 for this analytical laboratory instrument procurement. This contract falls under NAICS code 334516 (Analytical Laboratory Instrument Manufacturing) and is classified as a new requirement with no set-aside restrictions. Interested vendors should direct inquiries to the FDA's Acquisition Liaison at cderacquisitions@fda.hhs.gov.
Forecast text
The mIRage-LS sub-micron IR multimodal microscope system represents a cutting-edge analytical platform that integrates Optical Photothermal Infrared (O-PTIR) spectroscopy with simultaneous Raman and fluorescence microscopy capabilities. This system enables comprehensive particle characterization at spatial resolutions below 500nm, providing both chemical identification and morphological analysis in a single integrated workflow.
On GovTribe
Work this forecast
- Track it in your pipeline
- Find teaming partners
- Similar forecasts
- Ask GovTribe AI about this forecast